GlassScriptPhysician profile
Jorge L Rivera Mirabal
NPI 1720489446
$4,852.85
in general payments reported to CMS, 2019-2025
39 companies · $1,098 in 2025
The $1,098 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $544 · 2022: $581 · 2023: $1,353 · 2024: $1,276 · 2025: $1,098.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,727.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,727.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $727.93 | 2022-2025 | Myrisk, Prolaris, Precisetumor |
| Endo Pharmaceuticals INC. | $461.53 | 2021-2024 | Xiaflex, Aveed |
| Axonics, INC. | $377.86 | 2023-2024 | Axonics |
| Endo USA, INC. | $290.45 | 2024-2025 | Xiaflex, Aveed |
| Bayer Healthcare Pharmaceuticals INC. | $271.66 | 2022-2025 | |
| Astellas Pharma US INC | $256.97 | 2022-2025 | Myrbetriq, Xtandi, Veozah |
| Pfizer INC. | $250.76 | 2022-2025 | |
| Acerus Pharmaceuticals Corporation | $232.74 | 2021 | |
| Antares Pharma, INC. | $192.60 | 2022 | |
| Janssen Biotech, INC. | $186.09 | 2022-2024 | Erleada, Akeega |
| Sumitomo Pharma America, INC. | $155.58 | 2023-2025 | Orgovyx, Gemtesa |
| Abbvie INC. | $131.80 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $125.69 | 2024-2025 | Adstiladrin |
| Progenics Pharmaceuticals, INC. | $123.55 | 2025 | |
| Boston Scientific Corporation | $103.55 | 2021-2024 | Lithovue |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jorge Rivera Mirabal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.